课题基金 / 基金详情

CHEMOPREVENTION OF MNU-INDUCED MAMMARY TUMORS IN THE RAT

CHEMOPREVENTION OF MNU-INDUCED MAMMARY TUMORS IN THE RAT
MNU 诱导的大鼠乳腺肿瘤的化学预防
批准号:
2302625
负责人:
G CLINTON
金额:
$39.15万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1997-09-30

项目摘要

项目成果

G CLINTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chemoprevention of MNU-Induced Mammary Tumors in the Rat by combinations of chemopreventive Agents (Workstatement #61) Virgin, female Sprague- Dawley rats are being used to determine the efficacy of a series of combinations-of chemopreventive agents to prevent mammary cancer. The animals are being fed a diet consisting of standard laboratory chow (e.g. Teklad 4% Rodent Chow). The carcinogen, N-methyl-N-nitrosourea (MNU), administered at about 120 days of age, is used to induce mammary tumors . An MTD for each combination of agents is established and the chemoprevention experiment shall proceed at 0.8 MTD and 0.4 MTD of each combination. Doses for both the rangefinding and the combination tests shall be approved by the Project Officer. The chemopreventive agents is administered starting l week prior to the first carcinogen dose and given to the end of the experiment. The 9-cis-retinoic acid, DHEA, tamoxifen are being administered in the diet. Indole-3-carbinol and vorozole will be administered i.g. on a constant mg/kg body weight basis. Blood levels and food consumption are being determined for each agent (where practicable). The rats are sacrificed at the end of the experiment at 150 days after the carcinogen dose or when moribund. The number of mammary tumors per animal, and the percent of animals with tumors, and the mean tumor latency (mean time to first tumor) shall be recorded for each group. The mammary tumors shall be excised and a mean tumor weight established for each group. A histological diagnosis shall be made on each tumor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL EVALUATIONS OF INTERMEDIATE ENDPOINTS
国内基金
海外基金
感光细胞特异性表达基因NDRG2协同雌激素阻断MNU诱导视网膜色素变性的分子机制研究
  • 批准号:
    81870676
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    俞小瑞
  • 依托单位:
MNU诱导P53+/-小鼠模型中T细胞淋巴瘤早期发生关键基因筛查
  • 批准号:
    81502396
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    吴曦
  • 依托单位: